Newswire (Published: Tuesday, October 15, 2019, Received: Tuesday, October 15, 2019, 4:28:48 PM CDT)

Word Count: 442

2019 OCT 15 (NewsRx) -- By a News Reporter-Staff News Editor at Disease Prevention Daily -- Investigators publish new report on Oncology - Prostate Cancer. According to news reporting out of London, United Kingdom, by NewsRx editors, research stated, “Prostate cancer is one of the most common cancers in men which remains a global public health issue. Treatment of prostate cancer is becoming increasingly intensive and aggressive, with a corresponding increase in resistance, toxicity and side effects.”

Our news journalists obtained a quote from the research from Princess Grace Hospital, “This has revived an interest in nontoxic and cost-effective preventive strategies including dietary compounds due to the multiple effects they have been shown to have in various oncogenic signalling pathways, with relatively few significant adverse effects. To identify such dietary components and micronutrients and define their prostate cancer-specific actions, we systematically reviewed the current literature for the pertinent mechanisms of action and effects on the modulation of prostate carcinogenesis, along with relevant updates from epidemiological and clinical studies. Evidence from various recent experimental, clinical and epidemiological studies indicates that select dietary micronutrients (i.e., lycopene, epigallocatechin gallate, sulforaphane, indole-3-carbinol, resveratrol, quercetin, curcumin & piperine) and zinc play a key role in prostate cancer prevention and progression and therefore hold great promise for the future overall management of prostate cancer.”

According to the news editors, the research concluded: “A formulation that comprises these micronutrients using the optimal, safest form and dosing should be investigated in future prostate cancer chemoprevention studies and as part of standard prostate cancer therapy.”

For more information on this research see: Chemoprevention of Prostate Cancer by Natural Agents: Evidence from Molecular and Epidemiological Studies. Anticancer Research, 2019;39(10):5231-5259. Anticancer Research can be contacted at: INT Inst Anticancer Research, Editorial Office 1ST km Kapandritiou-Kalamou Rd Kapandriti, PO Box 22, Athens 19014, Greece. (International Institute of Anticancer Research - http://www.iiar-anticancer.org/; Anticancer Research - http://www.iiar-anticancer.org/main.php?id=2)

Our news journalists report that additional information may be obtained by contacting K. Mokbel, London Breast Institute, Princess Grace Hospital, London, UK. Additional authors for this research include U. Wazir and K. Mokbel.

The direct object identifier (DOI) for that additional information is: https://doi.org/10.21873/anticanres.13720. This DOI is a link to an online electronic document that is either free or for purchase, and can be your direct source for a journal article and its citation.

Publisher contact information for the journal Anticancer Research is: INT Inst Anticancer Research, Editorial Office 1ST km Kapandritiou-Kalamou Rd Kapandriti, PO Box 22, Athens 19014, Greece.

(Our reports deliver fact-based news of research and discoveries from around the world.)

Places

Northern Europe
Southern Europe
United Kingdom
Greece
Europe
England
London
Athens

Subjects

Science and Technology
      Scientific Research
Health and Wellness
      Medical Conditions and Diseases
            Cancer
                  Prostate Cancer
            Men's Health Issues
                  Prostate Cancer